QuantaMatrix Inc.
QuantaMatrix Inc. operates as an in-vitro diagnostics company in South Korea. Its products include dRAST, a direct and rapid antimicrobial susceptibility test for treating sepsis that provides MIC-based phenotypic antimicrobial susceptibility testing direct from positive blood culture; QDST, a rapid phenotypic drug susceptibility testing system for tuberculosis; QPLEX Alz plus assay, an early dia… Read more
QuantaMatrix Inc. (317690) - Total Assets
Latest total assets as of September 2025: ₩21.61 Billion KRW
Based on the latest financial reports, QuantaMatrix Inc. (317690) holds total assets worth ₩21.61 Billion KRW as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
QuantaMatrix Inc. - Total Assets Trend (2017–2024)
This chart illustrates how QuantaMatrix Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
QuantaMatrix Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
QuantaMatrix Inc.'s total assets of ₩21.61 Billion consist of 71.5% current assets and 28.5% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩6.11 Billion | 22.8% |
| Accounts Receivable | ₩509.03 Million | 1.9% |
| Inventory | ₩2.06 Billion | 7.7% |
| Property, Plant & Equipment | ₩3.92 Billion | 14.6% |
| Intangible Assets | ₩1.70 Billion | 6.4% |
| Goodwill | ₩0.00 | 0.0% |
Asset Composition Trend (2017–2024)
This chart illustrates how QuantaMatrix Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: QuantaMatrix Inc.'s current assets represent 71.5% of total assets in 2024, a decrease from 78.2% in 2017.
- Cash Position: Cash and equivalents constituted 22.8% of total assets in 2024, up from 0.6% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 6.0% of total assets, an increase from 3.0% in 2017.
- Asset Diversification: The largest asset category is cash and equivalents at 22.8% of total assets.
QuantaMatrix Inc. Competitors by Total Assets
Key competitors of QuantaMatrix Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
|
China | CN¥5.17 Billion |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
|
China | CN¥16.67 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥4.55 Billion |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
|
China | CN¥6.10 Billion |
|
Shinhung
KO:004080
|
Korea | ₩153.50 Billion |
|
UMediC Group Berhad
KLSE:0256
|
Malaysia | RM94.93 Million |
|
Osang Healthcare Co.,Ltd
KQ:036220
|
Korea | ₩287.70 Billion |
|
HansBiomed Corporation
KQ:042520
|
Korea | ₩126.41 Billion |
QuantaMatrix Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - QuantaMatrix Inc. generates 0.09x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - QuantaMatrix Inc. is currently not profitable relative to its asset base.
QuantaMatrix Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.17 | 1.04 | 26.18 |
| Quick Ratio | 0.91 | 0.97 | 25.50 |
| Cash Ratio | 0.00 | 0.49 | 0.00 |
| Working Capital | ₩2.17 Billion | ₩ 839.52 Million | ₩ 53.50 Billion |
QuantaMatrix Inc. - Advanced Valuation Insights
This section examines the relationship between QuantaMatrix Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 10.20 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 18.4% |
| Total Assets | ₩26.83 Billion |
| Market Capitalization | $41.89 Million USD |
Valuation Analysis
Below Book Valuation: The market values QuantaMatrix Inc.'s assets below their book value (0.00 x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: QuantaMatrix Inc.'s assets grew by 18.4% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for QuantaMatrix Inc. (2017–2024)
The table below shows the annual total assets of QuantaMatrix Inc. from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩26.83 Billion | +18.36% |
| 2023-12-31 | ₩22.67 Billion | -50.29% |
| 2022-12-31 | ₩45.60 Billion | -28.49% |
| 2021-12-31 | ₩63.77 Billion | +3.60% |
| 2020-12-31 | ₩61.55 Billion | +85.45% |
| 2019-12-31 | ₩33.19 Billion | +4.59% |
| 2018-12-31 | ₩31.73 Billion | +130.91% |
| 2017-12-31 | ₩13.74 Billion | -- |